Navigation Links
Princeton team learns why some drugs pack such a punch
Date:8/20/2009

constructed proteins stuck to the ribosome, jamming the translocator in the bacteria.

"This is very similar to plugging the translocator with a folded protein and, sure enough, this also causes translocator destruction," Silhavy said. "It's like putting an anchor on the spaghetti instead of a knot. They are stuck and dead forever."

Researchers had been confused as to why these antibiotics seemed to be so adept at killing some kinds of bacteria more quickly than others. These experiments provide an explanation. Translocators are essential for life and, if some bacteria have fewer translocators from the start, then they are more vulnerable to such an attack.

"While it has been known for many years that these antibiotics work by inhibiting bacterial protein synthesis, it was not clear why some bacteria in a population appeared more susceptible than others," van Stelten said. "Our work has identified a new reason why these antibiotics are lethal to bacteria that may help explain these earlier findings."

The researchers made their discovery not because of a new piece of equipment or a new technique. "Like the vast majority of advancements in science and medicine, we happened upon this remarkable answer through basic research," van Stelten said.

The finding could have important implications for medicine.

"If we are to have any hope of outpacing the antibiotic resistance obtained by bacteria, it is paramount that we fully understand the mechanism of action of the antibiotics we currently use," van Stelten said. "Unfortunately, this is often very difficult as evidenced by the fact that, 50 years on, we are still learning new things about them."

Their work also produced another important result. When the translocators in bacteria became jammed by errant proteins, the researchers observed that the translocators emitted a molecular signal -- a stress response -- that called in a destructive enzyme known as the F
'/>"/>

Contact: Kitta MacPherson
kittamac@princeton.edu
609-258-5729
Princeton University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Princeton teams analysis of flu virus could lead to better vaccines
2. Princeton geoscientist offers new evidence that meteorite did not wipe out dinosaurs
3. Princeton researchers discover new type of laser
4. Princeton-led team finds secret ingredient for the health of tropical rainforests
5. Gift of $100 million to transform energy and environment research at Princeton
6. Princeton engineers develop low-cost recipe for patterning microchips
7. Computer learns dogspeak
8. Novel polymer could improve protein-based drugs
9. Anti-psychotic drugs could help fight cancer
10. NTU professor discovers method to efficiently produce less toxic drugs using organic molecules
11. When it comes to brain damage, blankets take the place of drugs

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Princeton team learns why some drugs pack such a punch
Princeton team learns why some drugs pack such a punch
(Date:11/25/2009)... just as vital to your health as what you eat, fou...l Studies. Their experiments in mice revealed that... in the liverthe body,s metabolic clearinghouseis ...dy,s circadian clock as conventional wisdom had it... a large number of genes completely independent of...
(Date:11/24/2009)...bby arteries from collapsing have been true life-s...onger needed -- once the arteries are strengthened... no choice but to leave them in place. , Prof. M...t of Biomedical Engineering has developed a new pa...re they,re needed, then dissolves. , "Our new co...
(Date:11/24/2009)...matter of debate. A high-profile study a few years...their carbon from trees and leaves, evidence for a...ic ecosystems. , But new research from the Unive... true. Algae provide a much richer diet for fish a...shed this week in the Proceedings of the National...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Greg Fischer Named AvMed Health Plans New Senior Vice President of Sales and Marketing 53911 1Greg Fischer Named AvMed Health Plans New Senior Vice President of Sales and Marketing 53911 2Omega Protein Reports 2009 Second Quarter Results 53906 1Omega Protein Reports 2009 Second Quarter Results 53906 2Omega Protein Reports 2009 Second Quarter Results 53906 3Omega Protein Reports 2009 Second Quarter Results 53906 4Omega Protein Reports 2009 Second Quarter Results 53906 5Omega Protein Reports 2009 Second Quarter Results 53906 6GenVec Reports Second Quarter 2009 Financial Results 13434 1GenVec Reports Second Quarter 2009 Financial Results 13434 2GenVec Reports Second Quarter 2009 Financial Results 13434 3GenVec Reports Second Quarter 2009 Financial Results 13434 4GenVec Reports Second Quarter 2009 Financial Results 13434 5GenVec Reports Second Quarter 2009 Financial Results 13434 6GenVec Reports Second Quarter 2009 Financial Results 13434 7
...nthetically engineered tissues such as muscle or c...orward, Cornell engineers describe in the journal ...e developed that can nourish growing tissues., The...a water-based gel that mimic a vascular system at ...l nutrients and growth factors to feed individual ...
...chi, Ph.D., distinguished professor of human genet...Institute of Human Genetics and a Howard Hughes Me...el Prize in Physiology or Medicine. , The announc...at the Karolinska Institute, in Stockholm, Sweden....ment of knockout mice technology, a gene-targeting...
...earchers at Columbia University Mailman School of ...n dramatically lower blood arsenic levels in indiv...nking water. This toxic element, naturally presen... a significant public health problem in at least 7...s and also parts of the U.S. Chronic arsenic expo...
Other Biology News:Researchers create system to build transplant tissue 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 3Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study 2Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study 3
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...S, Calif., May 6 Amgen (Nasdaq: AMGN ), today a... Meeting of Stockholders, held at The St. Regis Ho...cent of outstanding shares were represented at the...ore, Frank J. Biondi, Jr., Francois de Carbonnel, ...uck, Frank C. Herringer, Gilbert S. Omenn, Judith ...
...ay 6 ChanTest, the leading expert in ion channels... drug discovery, development, and safety -- is one...through Ohio,s Third Frontier Research and Commerc...terim Director of the Ohio Department of Developme..., Mark Barbash, announced the competitive grants l...
...y 6 /PRNewswire/ - Technology experts from over 20...ns on energy and the environment, topics of global...icromachine Summit is an international forum to di...ologies and the way in which they deliver economic...ue amongst the delegates of scientists, researcher...
Other Biology Technology:Amgen Announces Voting Results Of Annual Meeting Of Stockholders 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3World Micromachine Summit highlights technologies impacting energy and the environment 2
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Silencer siRNA Starter Kit from Ambion
Goat Anti-VAV2 Antibody, Unconjugated from Raybiotech, Inc.
Anti-Indoleamine 2,3-dioxygenase (IDO) Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: